-
Mashup Score: 4
The combination of a talquetamab and teclistamab induced durable responses among patients with relapsed or refractory multiple myeloma, according to phase 1B/phase 2 study results.“Combination therapy with teclistamab plus talquetamab showed encouraging antitumor activity in a majority of patients with relapsed or refractory multiple myeloma,” Yael C. Cohen, MD, head of the myeloma
Source: www.healio.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1Real-world outcomes with bispecific T-cell engagers in lymphoma worse than pivotal trials - 2 day(s) ago
SAN DIEGO — Patients with relapsed or refractory large B-cell lymphoma who received epcoritamab or glofitamab in real-world settings achieved worse survival outcomes than those who received the agents in pivotal trials.Immune effector cell-associated neurotoxicity syndrome (ICANS) and grade 3 or greater cytokine release syndrome also occurred at higher rates in real-world settings, data
Source: www.healio.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1
Although the insertion of inferior vena cava filters declined between 2013 and 2021, the rate of retrievals remained low, according to a study published in JAMA.In the retrospective observational cohort study, researchers evaluated Medicare fee-for-service data on 270,866 patients (mean age, 75.1 years; 52.8% women) implanted with inferior vena cava (IVC) filters from 2013 through 2021.
Source: www.healio.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0Survey shows radiation oncology in ‘dark place’ as prior authorization burden worsens - 2 day(s) ago
An American Society of Radiation Oncology survey has shined a spotlight on the impact prior authorization has on providers and patients.Nearly one-third of the more than 750 radiation oncologists who participated in the survey indicated prior authorization delays led to ED visits, hospitalization or permanent disability for their patients.
Source: www.healio.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 3‘More rigorous’ discussion needed about potential complications after prostate cancer therapy - 3 day(s) ago
Men treated with radiotherapy and prostatectomy for prostate cancer exhibit significantly higher risk for numerous urinary and sexual complications compared with the general population, according to results of a cohort study.Urinary incontinence, sexual dysfunction and secondary malignancies are among the known adverse events that can occur after prostate cancer treatment.
Source: www.healio.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1
The Association of Cancer Care Centers launched a fundraising initiative to support the Firefighter Cancer Support Network.The association will match donations up to $10,000.
Source: www.healio.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 4
Women diagnosed with advanced breast cancer appeared more likely than those with earlier-stage breast cancer to have pre-existing cardiovascular disease, according to results of a retrospective study.The association persisted among women with locally advanced or metastatic breast cancer, as well as for those with hormone receptor-positive disease.
Source: www.healio.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1
Adjuvant cemiplimab prolonged DFS compared with placebo for certain patients with cutaneous squamous cell carcinoma, according to the agent’s manufacturer. Cemiplimab (Libtayo, Regeneron Pharmaceuticals) — a fully human PD-1-blocking antibody — is approved in the United States for treatment of people with cutaneous squamous cell carcinoma that spread or cannot be cured by
Source: www.healio.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0Program expands access to guideline-concordant cancer care for adolescents, young adults - 4 day(s) ago
A program designed to better meet the needs of adolescents and young adults with cancer helped ensure more of them had access to guideline-concordant care, according to study findings. Jacob N. Stein, MD, MPH, assistant professor of oncology at The University of North Carolina at Chapel Hill, and colleagues retrospectively reviewed electronic health record and state cancer registry data to
Source: www.healio.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 4
Obesity at cancer diagnosis appeared linked to significantly poorer survival among children and adolescents, according to results of a retrospective study.The association between obesity and mortality risk appeared strongest among those with acute lymphoblastic leukemia or central nervous system tumors.
Source: www.healio.comCategories: General Medicine News, Oncologists1Tweet
The combination of a talquetamab and teclistamab induced durable responses among patients with relapsed or refractory multiple myeloma. Nearly two-thirds of patients in the study developed grade 3 or grade 4 infections. #Talvey #Tecvayli https://t.co/qfQWg5Sy5B